Tower Research Capital (TRC)’s ESGEN Acquisition Corporation Unit ESACU Stock Holding History

Tower Research Capital (TRC)’s Portfolio ESACU Stock Details ESACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-274	Closed	-$2.97K	–	6277
2023 Q4	$2.97K	Hold	274	–	–	﹤0.01%	5144
2023 Q3	$3.09K	Hold	274	–	–	﹤0.01%	5054
2023 Q2	$3.13K	Hold	274	–	–	﹤0.01%	5106
2023 Q1	$3K	Hold	274	–	–	﹤0.01%	5277
2022 Q4	$3K	Hold	274	–	–	﹤0.01%	5280
2022 Q3	$3K	Hold	274	–	–	﹤0.01%	5462
2022 Q2	$3K	Sell	274 -144	-34%	-$1.46K	﹤0.01%	5442
2022 Q1	$4K	Sell	418 -133	-24%	-$1.34K	﹤0.01%	5288
2021 Q4	$6K	Buy	+551	New	+$5.58K	﹤0.01%	5086

Tower Research Capital (TRC)'s ESACU Position: Q1 2024 in Review

Tower Research Capital (TRC) sold out of ESGEN Acquisition Corporation Unit (ESACU) in Q1 2024, closing a stake of 274 shares — an estimated $2.97K sold.

Tower Research Capital (TRC) first reported a position in ESACU in Q4 2021 and held it in 9 quarters. The position peaked at $6K in Q4 2021. 0 funds tracked by Wall St. Rank hold ESACU as of Q1 2024.

Tower Research Capital (TRC) reported no remaining ESGEN Acquisition Corporation Unit position as of Q1 2024 after selling out during the quarter.
Tower Research Capital (TRC) sold 274 ESGEN Acquisition Corporation Unit shares in Q1 2024, an estimated $2.97K.
Tower Research Capital (TRC) first reported a position in ESGEN Acquisition Corporation Unit in Q4 2021 and held it in 9 quarters.
Tower Research Capital (TRC)'s ESGEN Acquisition Corporation Unit position peaked at $6K in Q4 2021.
0 funds tracked by Wall St. Rank held ESGEN Acquisition Corporation Unit as of Q1 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.